Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34946 | 0.80 | — | — | |
| SCHEMBL34416 | 0.76 | — | — | |
| SCHEMBL21552154 | 0.76 | GAA (0.37) | GAA | |
| SCHEMBL28182018 | 0.76 | — | — | |
| SCHEMBL5577804 | 0.70 | GAA (0.45) | GAA | |
| SCHEMBL23230083 | 0.60 | SMN1; SMN2 (0.48) | GAA | |
| SCHEMBL6668560 | 0.59 | GABRP (0.34) | — | |
| SCHEMBL6672722 | 0.59 | GABRP (0.34) | — | |
| SCHEMBL28581138 | 0.56 | CA1 (0.44) | — | |
| SCHEMBL231128 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10500230-B2 | Kidney-derived cells and methods of use in tissue repair and regeneration | DePuy Synthes Products, Inc. (US) | 2019-12-10 | — | — | US | claimed |
| US-11357756-B2 | Anesthetic compositions and methods comprising imidazoline compounds | WARSAW ORTHOPEDIC, INC. (US) | 2022-06-14 | — | — | US | disclosed |
| EP-3831345-A1 | HIP JOINT DEVICE, SYSTEM AND METHOD | Implantica Patent Ltd. (SE) | 2021-06-09 | — | — | EP | disclosed |
| US-20210161570-A1 | COMPOSITION, METHOD AND DEVICE FOR STABILIZING IMPLANTED HYDRAULIC DEVICES | FORSELL PETER (CH) | 2021-06-03 | — | — | US | disclosed |
| US-10939942-B2 | Composition, method and device for stabilizing implanted hydraulic devices | FORSELL PETER (CH) | 2021-03-09 | — | — | US | disclosed |
| EP-3087955-B1 | HIP JOINT DEVICE | Implantica Patent Ltd (SE) | 2020-12-30 | — | — | EP | disclosed |
| EP-2945568-B1 | CLONIDINE COMPOUNDS IN A BIODEGRADABLE FIBER | WARSAW ORTHOPEDIC INC (US) | 2020-08-19 | — | — | EP | disclosed |
| US-10500230-B2 | Kidney-derived cells and methods of use in tissue repair and regeneration | DePuy Synthes Products, Inc. (US) | 2019-12-10 | — | — | US | disclosed |
| US-10463471-B2 | Methods and devices for positioning and securing ligament grafts | MEDOS INTERNATIONAL SARL (CH) | 2019-11-05 | — | — | US | disclosed |
| US-20190307691-A1 | HYDROGELS WITH LIPOSOMES FOR CONTROLLED RELEASE OF DRUGS | NORTHERN ILLINOIS RESEARCH FOUNDATION | 2019-10-10 | — | — | US | disclosed |
| US-6423252-B1 | Methods of making micropatterned foams | ETHICON, INC. | 2002-07-23 | — | — | US | disclosed |
| EP-1216717-A1 | Reinforced tissue implants and methods of manufacture and use | ETHICON, INC. (US) | 2002-06-26 | — | — | EP | disclosed |
| EP-1216718-A1 | Reinforced foam implants for soft tissue repair and regeneration | ETHICON, INC. (US) | 2002-06-26 | — | — | EP | disclosed |
| US-6365149-B2 | Porous tissue scaffoldings for the repair or regeneration of tissue | ETHICON, INC. | 2002-04-02 | — | — | US | disclosed |
| US-6355699-B1 | SOLIDIFYING SOLUTION OF SOLVENT AND BIOCOMPATIBLE POLYMER; SUBLIMATION OF SOLVENT; TISSUE ENGINEERING; FREEZE DRYING | ETHICON, INC. | 2002-03-12 | — | — | US | disclosed |
| EP-1166987-A2 | Methods of making micropatterned foams | ETHICON, INC. (US) | 2002-01-02 | — | — | EP | disclosed |
| US-6333029-B1 | POROUS BIOCOMPATIBLE, BIOABSORBABLE FOAMS THAT SERVE AS A TEMPLATE FOR TISSUE REGENERATION, REPAIR OR AUGMENTATION | ETHICON, INC. | 2001-12-25 | — | — | US | disclosed |
| US-20010033857-A1 | Porous tissue scaffoldings for the repair or regeneration of tissue | ENDO-SURGERY, INC. | 2001-10-25 | — | — | US | disclosed |
| US-6306424-B1 | POROUS BIOCOMPATIBLE BIOABSORBABLE FOAMS THAT HAVE A GRADIENT IN AND/OR MICROSTRUCTURE THAT SERVE AS A TEMPLATE FOR TISSUE REGENERATION, REPAIR OR AUGMENTATION | ETHICON, INC. | 2001-10-23 | — | — | US | disclosed |
| EP-1064958-A1 | Porous tissue scaffoldings for the repair or regeneration of tissue | ETHICON, INC. (US) | 2001-01-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11357756-B2 | Anesthetic compositions and methods comprising imidazoline compounds | OPRK1, ADRA2C, ADRB2 | GAA 4174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.